Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DJVB | ISIN: FR0014005I80 | Ticker-Symbol: G3O
Frankfurt
13.05.26 | 08:05
7,540 Euro
-0,79 % -0,060
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
S.M.A.I.O SA Chart 1 Jahr
5-Tage-Chart
S.M.A.I.O SA 5-Tage-Chart
RealtimeGeldBriefZeit
7,9008,08013.05.

Aktuelle News zur S.M.A.I.O SA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11%229Revenue in the United States reached a record quarterly high of €2.3 million (+21%), or $2.6 million (+35%)1 excluding currency effects The United States accounts for nearly 80% of the...
► Artikel lesen
MoSMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon224Appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal conditions SMAIO's Scientific Advisory Board, now comprised of five members, is a key asset in...
► Artikel lesen
05.05.SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating360Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN Code: FR0014005I80 Ticker: ALSMA), a French-American company specialized in complex...
► Artikel lesen
06.03.SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum420Capital increase totaling €3.6 million gross through the issuance of shares with stock warrants (ABSAs) at a price of €7 per share 4 warrants will entitle the holder to subscribe for one...
► Artikel lesen
20.01.SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67%370U.S. sales rose by +138% to €7m, and by +160% to $7.9m (excluding currency effects). Strong growth across North American centers that were already active in 2024 (+130%). 11 new...
► Artikel lesen
08.01.SMAIO: 2026 Financial Calendar468Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN: FR0014005I80 Ticker: ALSMA), a French-American player specialized in complex spine...
► Artikel lesen
S.M.A.I.O SA Aktie jetzt für 0€ handeln
06.01.SMAIO Obtains €2.0m in Non-Dilutive Financing443€1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years €1.0m...
► Artikel lesen
19.12.25SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States575New attendance record at the New York session, bringing together nearly 60 experts from the spine sector, including over 40 surgeons Regulatory News: SMAIO (Software, Machines and Adaptative...
► Artikel lesen
24.11.25SMAIO appoints Matthieu Ville as chief commercial officer8
24.11.25SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment333Matthieu Ville brings over 15 years of experience in medical marketing in the United States. Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics- Euronext Growth...
► Artikel lesen
03.11.25SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States326Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board...
► Artikel lesen
22.10.25SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S.532Orthofix is a global medical technology company focused on healing musculoskeletal pathologies The distribution arrangement is part of SMAIO's collaborative strategy aimed at deploying...
► Artikel lesen
14.10.25SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025340Strong sales growth in H1 2025: +126% to €5.0 million Increase in gross margin in H1 2025 to 85% vs. 64% in H1 2024 Significant improvement in EBITDA (+96%) reaching break-even (vs....
► Artikel lesen
24.09.25SMAIO Signs the First Major Distribution Agreement for Its Open Platform KEOPS-4ME with Highridge Medical in the U.S.434Highridge Medical is one of the world's largest privately held spine companies The partnership represents a key milestone in further expanding SMAIO's business activity in the U.S. and driving...
► Artikel lesen
16.07.25SMAIO Announces Significant Sales Increase in H1 2025434Sales H1 2025: +126% to €5 million Acceleration of business activity in the United States (+360% to €3.8 million): H1 2025 sales1 higher than full-year 2024 sales More than...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1